OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Your search returned 18 results. Expanded Search
Genes match for NM_001128921   Similar terms to NM_001128921

   MARK3   (cTAK1;C-TAK1;KP78;PAR1A;)

Citation  Cited in Publication(s)       15,000 ORF clones at $98 each

|<<     <<      >>     >>|   total pages:0
SKU   Category   Expression Host   Description   $ Price   Availability  
  TP760895     Protein E.coli Purified recombinant protein of Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5, full length, with N-terminal HIS tag, expressed in E. coli, 50ug 199 In Stock
  LY427023     Lysate HEK293T Transient overexpression lysate of MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5 280 5 days
TrueORF Gold TrueORF Gold = Expression Validated + Sequence Verified + Next-day shipment!
SKU   Category   Vector   Tag   Description   $ Price   Availability  
  RC226070     TrueORF Gold TrueORF Gold pCMV6-Entry Myc-DDK MARK3 (Myc-DDK-tagged)-Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5 810 In Stock
  RC226070L1V     Human LentiORF Particles pLenti-C-Myc-DDK Myc-DDK Lenti ORF particles, MARK3 (Myc-DDK tagged) - Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5 , 0.5 mL, >10^6 TU/mL 1390 2-3 weeks
  RC226070L2V     Human LentiORF Particles pLenti-C-mGFP mGFP Lenti ORF particles, MARK3 (mGFP-tagged) - Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5, 0.5 mL, >10^6 TU/mL 1530 2-3 weeks
  RC226070L1     Human Lenti-ORF pLenti-C-Myc-DDK Myc-DDK Lenti ORF clone of Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5 , Myc-DDK-tagged 990 In Stock
  RC226070L2     Human Lenti-ORF pLenti-C-mGFP mGFP Lenti ORF clone of Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5, mGFP tagged 1090 In Stock
  RG226070     Human Clone pCMV6-AC-GFP TurboGFP MARK3 (GFP-tagged) - Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5 900 2-3 weeks
  SC323168     Human Clone pCMV6-Entry No tags MARK3 (untagged)-Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 5 1020 2-3 weeks
SKU   Category   Format   Vector   Description   $ Price   Availability  
  TL320413     Human shRNA Lentiviral Plasmid pGFP-C-shLenti MARK3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TG320413     Human shRNA Retroviral Plasmids pGFP-V-RS MARK3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 650 2 Weeks
  TF320413     Human shRNA Retroviral Plasmids pRFP-C-RS MARK3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 498 In Stock
  TR320413     Human shRNA Retroviral Plasmids pRS MARK3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 650 2 Weeks
  SR302809     Human siRNA MARK3 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 300 In Stock
  TL501302     Mouse shRNA Lentiviral Plasmid pGFP-C-shLenti MARK3 - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
  TL712542     Rat shRNA Lentiviral Plasmid pGFP-C-shLenti MARK3 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 2 Weeks
SKU   Category  
Description   $ Price   Availability  
  SC208184     3'-UTR Clone pMirTarget 3`UTR clone of MAP/microtubule affinity-regulating kinase 3 (MARK3) transcript variant 5 for miRNA target validation 510 3-4 weeks
SKU   Category   Description   $ Price   Availability  
  KN205758     knockout MARK3 - human gene knockout kit via CRISPR 1200 4 Weeks
Circling Loader
Loading message
Inc 5000 Healthcare Company
All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title